Epigenetics Market 2018 Global Trend, Segmentation and Opportunities Forecast To 2023

Epigenetics
Epigenetics -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2023

Epigenetics Industry

Description

Wiseguyreports.Com Adds “Epigenetics -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2023” To Its Research Database

Global Epigenetics Market is accounted for $752.8 million in 2016 and expected to grow at a CAGR of 14.0% to reach $1891.9 million by 2023. Growing prevalence of cancer and other chronic diseases are helping the market to compete across the globe. Some of the major factors that are influencing the market include growing technological advancements, rising R&D expenditure, growing usage for non-oncology diseases, improving collaborations between pharmaceutical, biotechnology companies & academic research institutes and increasing geriatric population base. However, huge equipment cost, lack of predictive markers, inefficiency in identification and validation of biomarkers, presence of complicated regulatory framework and shortage of skilled professional are hampering the market growth.

Based on Technology, DNA methylation can be classified as hyper and hypomethylation. Reduced representation bisulfite sequencing (RRBS) is a DNA wide methylation analysis technique for a combination of enrichment and modifying techniques. DNA methylation is also used as a biomarker for early cancer diagnosis. The FDA-approved epigenetic drugs are demethylating agents, and most of the diagnostic activity to date in epigenetics has focused on methylation markers.

Based on End User, with in the pharmaceutical sector, the therapeutic applications of epigenetics have fascinated a large and growing number of pharmaceutical and biopharmaceutical companies. Over 40 companies that are now active. Venture capital-funded companies in epigenetics include Constellation Pharmaceuticals and Syndax Pharmaceuticals.

North America dominated the overall revenue, due to the, increasing funds for R&D, growing collaborations between large pharmaceutical firms and demand for epigenetic drugs and diagnostic technologies. However, Asia-Pacific is anticipated to grow rapidly, due to high incidence of cancer, large prevalence of target diseases and rise in healthcare expenditure.

Some of the key players in Global Epigenetics market are Celgene Corporation, CellCentric Ltd, Chroma Therapeutics Ltd, Covaris Inc, DIAGENODE, INC., Ribimed Biotechnologies, Epigenomics AG, Epitherapeutics, Epizyme, Karus Therapeutics, Merck Millipore, Novartis International AG, Oncolys Biopharma Inc, OncoMethylome Sciences, Qiagen, Sigma-Aldrich Corporation, Syndax Pharmaceuticals and ZYMO RESEARCH CORPORATION (ZYMO).

Products Covered: 
• Enzymes 
• Reagents 
• Kits 
• Instruments and Consumables

Request for Sample Report @ https://www.wiseguyreports.com/sample-request/2768986-epigenetics-global-market-outlook-2017-2023

Technologies Covered: 
• Histone Methylation 
• DNA Methylation 
• Histone Acetylation 
• Large noncoding RNA 
• Chromatin structures 
• MicroRNA Modification 
• Other Technologies

Applications Covered: 
• Cardiovascular Diseases 
• Developmental Biology 
• Immunology 
• Metabolic Diseases 
• Inflammatory Disease 
• Oncology 
• Other Applications

End Users Covered: 
• Pharmaceutical 
• Contract Research Organizations 
• Academic and Research Institutes 
• Biotechnology Companies

Regions Covered: 
• North America 
o US 
o Canada 
o Mexico 
• Europe 
o Germany 
o UK 
o Italy 
o France 
o Spain 
o Rest of Europe 
• Asia Pacific 
o Japan 
o China 
o India 
o Australia 
o New Zealand 
o South Korea 
o Rest of Asia Pacific 
• South America 
o Argentina 
o Brazil 
o Chile 
o Rest of South America 
• Middle East & Africa 
o Saudi Arabia 
o UAE 
o Qatar 
o South Africa 
o Rest of Middle East & Africa

Leave a Query @ https://www.wiseguyreports.com/enquiry/2768986-epigenetics-global-market-outlook-2017-2023

What our report offers: 
– Market share assessments for the regional and country level segments 
– Market share analysis of the top industry players 
– Strategic recommendations for the new entrants 
– Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets 
– Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) 
– Strategic recommendations in key business segments based on the market estimations 
– Competitive landscaping mapping the key common trends 
– Company profiling with detailed strategies, financials, and recent developments 
– Supply chain trends mapping the latest technological advancements

 

Table of Content

1 Executive Summary 

2 Preface 

3 Market Trend Analysis 

4 Porters Five Force Analysis 

5 Global Epigenetics Market, By Product 

6 Global Epigenetics Market, By Technology 

7 Global Epigenetics Market, By Application 

8 Global Epigenetics Market, By End User 

9 Global Epigenetics Market, By Geography 

10 Key Developments 

11 Company Profiling 
11.1 Celgene Corporation 
11.2 CellCentric Ltd 
11.3 Chroma Therapeutics Ltd, 
11.4 Covaris Inc 
11.5 DIAGENODE, INC. 
11.6 Ribimed Biotechnologies 
11.7 Epigenomics AG 
11.8 Epitherapeutics 
11.9 Epizyme 
11.10 Karus Therapeutics 
11.11 Merck Millipore 
11.12 Novartis International AG 
11.13 Oncolys Biopharma Inc 
11.14 OncoMethylome Sciences 
11.15 Qiagen 
11.16 Sigma-Aldrich Corporation 
11.17 Syndax Pharmaceuticals 
11.18 ZYMO RESEARCH CORPORATION (ZYMO) 

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=2768986

List of Tables 
Table 1 Global Epigenetics Market Outlook, By Region (2014-2023) ($MN) 
Table 2 Global Epigenetics Market Outlook, By Product (2014-2023) ($MN) 
Table 3 Global Epigenetics Market Outlook, By Enzymes (2014-2023) ($MN) 
Table 4 Global Epigenetics Market Outlook, By RNA-Modifying Enzymes (2014-2023) ($MN) 
Table 5 Global Epigenetics Market Outlook, By Protein-Modifying Enzymes (2014-2023) ($MN) 
Table 6 Global Epigenetics Market Outlook, By DNA-Modifying Enzymes (2014-2023) ($MN) 
Table 7 Global Epigenetics Market Outlook, By Reagents (2014-2023) ($MN) 
Table 8 Global Epigenetics Market Outlook, By Primers (2014-2023) ($MN) 
Table 9 Global Epigenetics Market Outlook, By Magnetic Beads (2014-2023) ($MN) 
Table 10 Global Epigenetics Market Outlook, By Histones (2014-2023) ($MN) 
Table 11 Global Epigenetics Market Outlook, By Buffers (2014-2023) ($MN) 

Continued…                       

 

Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (Us) Ph: +44 208 133 9349 (Uk)

 

Media Contact
Company Name: Wiseguyreports.com
Contact Person: Norah Trent
Email: Send Email
Phone: +1 646 845 9349, +44 208 133 9349
City: Pune
State: Maharashtra
Country: India
Website: https://www.wiseguyreports.com/sample-request/2768986-epigenetics-global-market-outlook-2017-2023